Company / Gross Profit
Celularity Inc Gross Profit History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$6.8M
FY2023
5-year range
-$1.7M / $11.7M
FY2021-FY2023
Trend
+499.7%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit changed +500% YoY in FY2023, a notable deviation from the 2-year average annual change of +193%.
Based on SEC 10-K filings.
$7M in FY2023.
Declined from $12M to $7M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, gross profit increased 499.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $6.8M | +499.7% |
| FY2022 | -$1.7M | -114.5% |
| FY2021 | $11.7M | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026